References
- Dautu G, Munyaka B, Carmen G, et al. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential. Exp Parasitol 2007;116:273-82. https://doi.org/10.1016/j.exppara.2007.01.017
- Ismael AB, Sekkai D, Collin C, Bout D, Mevelec MN. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003;71:6222-8. https://doi.org/10.1128/IAI.71.11.6222-6228.2003
- Xiang W, Qiong Z, Li-peng L, Kui T, Jian-wu G, Heng-ping S. The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice. Vet Parasitol 2009;166:1-7. https://doi.org/10.1016/j.vetpar.2009.08.014
- Fang R, Nie H, Wang Z, et al. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet Parasitol 2009;164: 134-40. https://doi.org/10.1016/j.vetpar.2009.06.012
- Fang R, Feng H, Hu M, et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol 2012;187:140-6. https://doi.org/10.1016/j.vetpar.2011.12.007
- Qu D, Han J, Du A. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice. Parasitol Res 2013;112:2593-9. https://doi.org/10.1007/s00436-013-3425-0
- Ghaffarifar F, Naserifar R, Jafari Madrak M. Eukaryotic plasmids with Toxoplasma gondii dense granule antigen (GRA5) and microneme 3 (MIC3) genes as a cocktail DNA vaccine and evaluation of immune responses in BALB/C mice. J Clin Med Genomics 2014;3:121.
- Yang D, Liu J, Hao P, et al. MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum. Parasitol Res 2015;114:3791-9. https://doi.org/10.1007/s00436-015-4609-6
- Gong P, Cao L, Guo Y, et al. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice. Exp Parasitol 2016;166:131-6. https://doi.org/10.1016/j.exppara.2016.04.003
- Wang H, He S, Yao Y, et al. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Exp Parasitol 2009;122:226-32. https://doi.org/10.1016/j.exppara.2009.04.002
- Peng GH, Yuan ZG, Zhou DH, et al. Sequence variation in Toxoplasma gondii MIC4 gene and protective effect of an MIC4 DNA vaccine in a murine model against toxoplasmosis. J Anim Vet Adv 2010;9:1463-8. https://doi.org/10.3923/javaa.2010.1463.1468
- Peng GH, Yuan ZG, Zhou DH, et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009;27:6570-4. https://doi.org/10.1016/j.vaccine.2009.08.043
- Yan HK, Yuan ZG, Song HQ, et al. Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii. Clin Vaccine Immunol 2012;19:684-9. https://doi.org/10.1128/CVI.05578-11
- Liu MM, Yuan ZG, Peng GH, et al. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 2010;106:1079-84. https://doi.org/10.1007/s00436-010-1742-0
- Li ZY, Chen J, Petersen E, et al. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014;32:3058-65. https://doi.org/10.1016/j.vaccine.2014.03.042
- Tao Q, Fang R, Zhang W, et al. Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. Parasitol Res 2013;112:2871-7. https://doi.org/10.1007/s00436-013-3458-4
- Yuan ZG, Ren D, Zhou DH, et al. Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine 2013;31:3135-9. https://doi.org/10.1016/j.vaccine.2013.05.040
- Yan HK, Yuan ZG, Petersen E, et al. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Exp Parasitol 2011;128:38-43. https://doi.org/10.1016/j.exppara.2011.02.005
- Zheng B, Ding J, Chen X, et al. Immuno-efficacy of a T. gondii secreted protein with an altered thrombospondin repeat (TgSPATR) as a novel DNA vaccine candidate against acute toxoplasmosis in BALB/c mice. Front Microbiol 2017;8:216.
- Beghetto E, Nielsen HV, Del Porto P, et al. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis 2005;191:637-45. https://doi.org/10.1086/427660
- Pinzan CF, Sardinha-Silva A, Almeida F, et al. Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice. PLoS One 2015;10:e0143087. https://doi.org/10.1371/journal.pone.0143087
- Lourenco EV, Bernardes ES, Silva NM, Mineo JR, Panunto-Castelo A, Roque-Barreira MC. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes Infect 2006;8:1244-51. https://doi.org/10.1016/j.micinf.2005.11.013
- Nie H, Fang R, Xiong BQ, et al. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins. Vet Parasitol 2011;181:215-21. https://doi.org/10.1016/j.vetpar.2011.04.039
- Qu D, Yu H, Wang S, Cai W, Du A. Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vet Parasitol 2009;166:220-7. https://doi.org/10.1016/j.vetpar.2009.08.016
- Lee SH, Kim AR, Lee DH, Rubino I, Choi HJ, Quan FS. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection. PLoS One 2017;12:e0175644. https://doi.org/10.1371/journal.pone.0175644
- Yin H, Zhao L, Wang T, Zhou H, He S, Cong H. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection. Parasit Vectors 2015;8:498. https://doi.org/10.1186/s13071-015-1108-7
- Wang T, Yin H, Li Y, Zhao L, Sun X, Cong H. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes. Parasite 2017; 24:12. https://doi.org/10.1051/parasite/2017013
- Yu L, Yamagishi J, Zhang S, et al. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitol Int 2012;61:481-6. https://doi.org/10.1016/j.parint.2012.04.001
Cited by
- Seroepidemiological evaluation of Toxoplasma gondii immunity among the general population in southwest of Iran vol.42, pp.4, 2018, https://doi.org/10.1007/s12639-018-1047-2
- Research Progress of Antigens Related to the Process of Toxoplasma gondii Invading Host Cell vol.7, pp.6, 2018, https://doi.org/10.12677/ojns.2019.76068
- Acetonic Fraction of Bidens pilosa Enriched for Maturase K Is Able to Control Cerebral Parasite Burden in Mice Experimentally Infected With Toxoplasma gondii vol.6, pp.None, 2018, https://doi.org/10.3389/fvets.2019.00055
- A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii vol.38, pp.4, 2018, https://doi.org/10.1007/s10096-018-03442-6
- Antigenic Epitope Analysis and Efficacy Evaluation of GRA41 DNA Vaccine Against T. gondii Infection vol.64, pp.3, 2019, https://doi.org/10.2478/s11686-019-00091-3
- Toxoplasma gondii : Preventive and therapeutic effects of morphine and evaluation of treatment parameters of tachyzoites and infected macrophages in vitro and in a murine model vol.19, pp.None, 2020, https://doi.org/10.17179/excli2019-1961
- Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (CDPK7) Showed Potential Targets for Toxoplasma gondii Vaccine vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/9974509
- Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant vol.13, pp.5, 2018, https://doi.org/10.3390/pharmaceutics13050752
- Review of DNA Vaccine Approaches Against the Parasite Toxoplasma gondii vol.107, pp.6, 2018, https://doi.org/10.1645/20-157
- Bioinformatics analysis of calcium-dependent protein kinase 4 (CDPK4) as Toxoplasma gondii vaccine target vol.14, pp.1, 2018, https://doi.org/10.1186/s13104-021-05467-1